Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 

Aquentium Announces Air and Water Purification Equipment for Medical Marijuana Industry

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/14/2013 | 08:30pm CEST

Aquentium, Inc. (OTCQB: AQNM), a manufacturer of ozone air and water purification systems for commercial businesses, announced today that the company will begin manufacturing ozone air and water purification equipment designed for use by legal growers of medical marijuana in the United States and internationally.

"Aquentium believes that America is at the beginning of a 'Green Rush,' an ever-increasing interest in the rapidly growing industry surrounding what seems to be the beginning of the end of marijuana prohibition. There are now 18 states that permit medical marijuana for people suffering from a multitude of serious illnesses and disorders, while residents in the state of Washington and the state of Colorado have already voted for legalization regarding recreational use," stated Aquentium President Mark Taggatz.

The Aquentium ozone air systems are designed to eliminate unwanted odors, while the Aquentium water systems are designed to enhance growing by killing germs and diseases. Treating water with ozone will kill damaging bacteria and will sterilize the root base and growing media while providing roots with extra oxygen.

"Ozone is one of the most effective bactericides known. Waterborne diseases are controlled by the injected ozone, which destroys fungi, pathogenic bacteria, viruses and organochlorines. These disease-causing microbes can greatly reduce plant growth and yields or even destroy entire crops. Once it has done its job, any excess ozone will break down into oxygen, which super oxygenates the nutrient solution, promoting rapid healthy root development. Ozone is not harmful to beneficial aerobic bacteria that thrive in an oxygen-rich environment. Plants grow faster and healthier, producing higher yields," added Taggatz.

Proponents of medical marijuana argue that it can be a safe and effective treatment for the symptoms of cancer, AIDS, multiple sclerosis, pain, glaucoma, epilepsy, and other conditions. They cite dozens of peer-reviewed studies, prominent medical organizations, and the use of marijuana as medicine throughout world history.

Safe Harbor Statement: Certain statements in this news release may contain "forward-looking" information within the meaning of rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Act of 1934 and are subject to the safe harbor created by those rules. There can be no assurance that such forward-looking statements will be accurate and actual results and future events could differ materially from those anticipated in such statements.

Aquentium, Inc.
Mark Taggatz, President
951-674-9200
ir@aquentium.com


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news
Date Title
10:02a B.S.D. CROWN LTD : - Company Update
10:02a GLOBALDATA : Swings To Loss On One-Offs But Revenue Surges
10:01a KAZ MINERALS : Expected cost of Kazakh copper mine project down by $100M
10:01a DGAP-NEWS : Ringmetall gibt kleinere Akquisition in den USA und Veränderungen im Aufsichtsrat bekannt
10:01a DGAP-NEWS : Ringmetall announces minor acquisition in the USA and changes in the Supervisory Board
10:01a EUREKA RESOURCES : drill permit approved by the BLM
10:01a STARBUCKS : Purple hair? Starbucks doesn't care. Coffee chain relaxes employee dress code
10:01a DGAP-NEWS : RedHill Biopharma Ltd.: RedHill Biopharma Receives Additional U.S. Patent Covering RHB-105 Ahead of Confirmatory Phase III Study for H. pylori Infection
10:01a XTI Aircraft Re-Opens Investments; Takes Steps Toward Flying Prototype
10:01a ENANTA PHARMACEUTICALS : CHMP Grants Positive Opinion for Shorter Treatment Duration with AbbVie's VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) for Patients with Genotype 4 Chronic Hepatitis C with Compensated Cirrhosis (Child-Pugh A)
Latest news
Advertisement
Hot News 
2.82%William Hill says not clear Rank and 888 deal would enhance position
1.40%HISCOX : considers setting up new EU arm to weather Brexit
1.04%BT willing to give greater autonomy to Openreach unit - chairman
0.38%PHILIPS : Profit Lifted by Health Technology Business
2.24%SPEEDY HIRE : investor Toscafund calls for removal of executive chairman
Most Read News
07/24 FUELLING THE FIRE : new coal technologies spell disaster for climate
Most recommended articles
04:00aEUROZONE : German IFO business climate better than estimates at 108.3
03:33a ABERDEEN ASSET MANAGEMENT : says third quarter assets up on market, currency gains
03:32aDJHighlands Natural Resources to Pay $500,000 for Rights to Drill Six Wells
03:31aDJChina Shanghai Rubber Futures Closing Prices, Volume
03:30a SPEEDY HIRE : investor Toscafund calls for removal of executive chairman